Renault Nissan India Complete Healthcare Drive In Chengalpattu District – 20 Villages Benefitted (Press Release) | V3Cars

Renault Nissan India have announced the successful conclusion of their healthcare drive in 20 villages in Chengalpattu district in Tamil Nadu. The brand stated that the mobile medical van initiative helped almost 15,000 individuals in these villages. The healthcare drive held in Chengalpattu was a continuation of the healthcare initiative launched in Kanchipuram in 2021. A total of 35,000 individuals have benefitted from both the initiatives between 2021 and 2023.

Renault Nissan India Complete Healthcare Drive

Renault Nissan India organised the latest mobile medical van drive between January and October 2023, providing free medical consultation and first-level treatment to individuals. The medical van was driven every week from Monday to Friday across 20 villages at least once every month, ensuring constant healthcare support.

Also Read: Skoda Slavia And Kushaq Elegance Editions Launched In India

Note: If You Want to Buy a New Car, Calculate Car Loan EMI with V3Cars

Here’s what Renault Nissan have to say about the conclusion of the healthcare drive:

Chennai, 28 November 2023: Renault Nissan Automotive India Pvt Ltd (RNAIPL) has announced the successful conclusion of its Mobile Medical Van initiative for the year 2023. Staffed by a doctor and two nurses, RNAIPL’s Mobile Medical Van offers free medical check-ups and essential follow-up care at people’s doorsteps in villages that have limited access to healthcare facilities. 

RNAIPL operated the Mobile Medical Van between January and October 2023, supporting free medical consultation and first-level treatment for close to 15,000 beneficiaries across 20 villages in Chengalpattu district. The Medical Van operated every week from Monday to Friday, visiting each of the 20 villages at least once every month ensuring consistent healthcare support. 

In total, the Mobile Medical Van made 180 trips in 2023. Some of the common conditions diagnosed and treated by the Mobile Medical Van included fever, myalgia, upper and lower respiratory tract infections and other dermatological conditions. In case of conditions that were not immediately treatable, patients were referred to government primary health centres in nearby districts. 

Keerthi Prakash, Managing Director of RNAIPL, said, "We believe that communities that have an increased awareness of the importance of health as well as access to healthcare are those that can better contribute to the sustainable progress of society. RNAIPL’s Mobile Medical Van initiative is a small step to make quality healthcare more accessible to the communities near our plant. We take pride in the positive impact we have made on the lives of thousands of people here.”

RNAIPL first launched the Mobile Medical Van initiative in 2021 during the COVID-19 crisis. In that year, the van supported over 20,000 beneficiaries across 40 villages in Kanchipuram district, spreading awareness and information on prevention of COVID-19 and other diseases. 

RNAIPL’s Mobile Medical van also offers guidance on essential health matters such as vaccination, dengue prevention, anemia management, menstrual hygiene, diabetes care, hypertension management, as well as general health tips to foster a culture of health consciousness.

RNAIPL's dedication to making healthcare accessible has positively impacted the lives of thousands. The company remains committed to community welfare, continually exploring ways to make a positive contribution to society.

Also Read: MG Hector Plus Smart Discontinued; Price Increased By Up To Rs. 30,000

Note: Calculate Car Fuel Cost with V3Cars for India and Other Countries


Saloni Chaudhary

Saloni is a skilled wordsmith with a degree in journalism and mass communications. Saloni is also a poetess who likes to capture the essence of human experiences, leaving an indelible imprint on the hearts of those who encounter her art. From reading about fashion, she also likes to read about classic motorcycles and vintage cars.


Leave a Reply